Searched for
LEERINK PARTNERS
US Stock Market: US health insurers post best quarterly performance since pandemic eraU.S. health insurers posted strong first-quarter earnings, easing concerns over rising medical costs and claims pressures. Major players be...- US Stocks: Wave Life Sciences shares plunge 58% as data for high dose of obesity drug disappointsWave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement a...
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- US FDA reverses course, will review Moderna's revised flu vaccine applicationThe US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...
- S&P 500, Nasdaq and Dow Jones see big rise as heavyweight tech stocks witness rebound: Galecto sees 250% gain, Sonder Holdings plunges; check top gainers and losers on November 10 and here’s how top indices performedWall Street saw a sharp rise on Monday, November 10, 2025. Major US indices like the S&P 500 and Nasdaq surged. This rally was powered by N...
- S&P 500, Dow Jones, and Nasdaq futures flat after big gains from AI companies boost Wall Street; here’s how key indices performedWall Street experienced a strong start to the week, with major indices like the S&P 500, Nasdaq, and Dow Jones closing sharply higher. This...
- Wall Street jumps, Nvidia and Palantir lead AI surgeIndian markets saw a strong rebound on Monday. Major technology and AI-related companies like Nvidia and Palantir experienced significant g...
- Metsera accepts Pfizer's $10 billion bid in ongoing M&A battleMetsera has accepted Pfizer's $10 billion acquisition offer. This ends a bidding war with rival Novo Nordisk. Pfizer will pay $86.25 per sh...
- Trump eyes fresh tariff probe focused on foreign drug pricesPresident Trump is initiating a new investigation into drug prices, aiming to compel foreign nations to pay the same as Americans for their...
- Big US pharma stocks rise as Street reacts to Trump's tariff on drugsPresident Trump announced new 100 percent import taxes on branded pharmaceuticals. These tariffs begin October 1. Companies building US man...
- Trump plans 200% tariff on imported drugs, raising risk of higher US prices and shortagesUS President Donald Trump has threatened pharmaceutical import tariffs of up to 200 per cent, a move that experts warn could raise drug cos...
- The dark side of Wall Street: Bankers turn to this addictive drug to get through gruelling 90-hour work weeksWall Street's demanding work culture pushes young bankers to extreme lengths. Many use stimulants like Adderall to endure 20+ hour workdays...
- US stock market: Dow Jones, S&P 500 regain ground as US inflation report nearsU.S. stocks have sharply rallied in 2023, with the benchmark S&P 500 rising 17.7% this year, fueled by optimism around artificial intellige...
- Silicon Valley Bank subsidiary sold to management teamHealthcare investment firm SVB Securities announced Sunday that its management team would buy out the company from parent Silicon Valley Ba...
- SVB Financial to sell its I-banking business to management teamThe group will acquire SVB Securities for a combination of cash, repayment of an intercompany note, assumption of certain liabilities and a...
- Wall St seeks safety of Big Tech bets as election hangs in the balanceGains for Joe Biden in vote tallies in the swing states of Wisconsin and Michigan cooled initial selling of renewable energy, marijuana and...
- Aurobindo acquires 7 oncology drugs from spectrum for $300 millionNasdaq-listed Spectrum Pharmaceuticals has carved out its commercial business inclusive of seven marketed oncology injectable products, int...
- Amazon, Berkshire, JPMorgan name Atul Gawande CEO of healthcare ventureAmazon, Berkshire and JPMorgan announced the joint venture in January, saying US healthcare costs were rising too fast and holding back eco...
- CVS bid for Aetna: A $66 billion bet on cutting drug costsCVS, one of the largest U.S. pharmacy benefits managers, has offered to buy No. 3 health insurer Aetna for more than $200 per share, source...
- Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...
Load More
